In vivo imaging and tumor measurements indicated that compared to the control group, tumor growth rate, volume, and weight were significantly reduced in the MRPL21-knockdown group, while no significant differences were observed in the PARP1-overexpressing rescue group (Figs. 4G–J). This evidence concerns the gene MRPL21 and neoplasm.